For example, studies in prostate cancer [65-70], renal cell carcinoma [71], liver cancer [72], and breast cancer [73-75] have shown that AR activation can suppress cell proliferation, migration, and metastasis or induce apoptosis and differentiation programs counteracting malignant phenotypes. Here, AR is linked to hereditary clear cell renal cell carcinoma.